SHG · Healthcare
Drug Manufacturers - Specialty & Generic
Sichuan Biokin Pharmaceutical Co. Ltd. A (688506) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $118.40B, P/E ratio is 18.00, net margin is -41.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Sichuan Biokin Pharmaceutical Co. Ltd. A (688506) has a reported market cap of $118.40B (data as of 2026-03-29).
The price-to-earnings (P/E) ratio for Sichuan Biokin Pharmaceutical Co. Ltd. A (688506) is 18.00 (data as of 2026-03-29).
Dividend yield is not available in the current snapshot for Sichuan Biokin Pharmaceutical Co. Ltd. A (688506). Check the MyAverix Finance app for the latest dividend data.
Sichuan Biokin Pharmaceutical Co. Ltd. A (688506) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
688506 is listed on SHG.
Sichuan Biokin Pharmaceutical Co. Ltd. A (688506) reports a net margin of -41.7% (data as of 2026-03-29).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.